GSK CFO Performance Share Plan Award Vesting Notification

This Form 6-K reports the vesting of a 2023 Performance Share Plan award for GSK plc's Chief Financial Officer, Julie Brown. The award, originally granted on April 27, 2023, was part of the company's 2017 Performance Share Plan and vested on April 27, 2026, following the third anniversary of the grant. The award vested at 82% with 18% lapsing, consistent with other 2023 PSP awards that vested on February 13, 2026. A total of 243,880 ordinary shares vested for the CFO, with a market value based on the closing price of £20.16 per share on the vesting date. The vested shares are subject to an additional two-year holding period for the CFO. This transaction represents standard executive compensation plan activity and provides transparency regarding executive equity compensation arrangements at the pharmaceutical company.